Incidence of Bacteremia Following Argon Plasma Coagulation in Patients With Endobronchial Lesions
1 other identifier
observational
46
1 country
1
Brief Summary
Incidence of Bacteremia Following Argon Plasma Coagulation in Patients with Endobronchial Lesions
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 8, 2010
CompletedFirst Posted
Study publicly available on registry
August 10, 2010
CompletedStudy Start
First participant enrolled
October 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedMarch 13, 2013
March 1, 2012
2 years
August 8, 2010
March 12, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The bacteremic rate following APC in patients with endobronchial involvment.
Two years
Eligibility Criteria
50 patients that undergo bronchoscopy with the use of APC
You may qualify if:
- All patients that undergo bronchoscopy with the use of APC
You may not qualify if:
- All patients under 18 years old All Patients with evidence of current respiratory infection or febrile illnesses and those that will receive antibiotic therapy within a week prior to the bronchoscopy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Meir MC
Kfar Saba, Israel, 49100, Israel
Related Publications (1)
Matveychuk A, Guber A, Talker O, Shitrit D. Incidence of bacteremia following bronchoscopy with argon plasma coagulation: a prospective study. Lung. 2014 Aug;192(4):615-8. doi: 10.1007/s00408-014-9583-8. Epub 2014 Apr 27.
PMID: 24770443DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
DAVID SHITRIT, MD
Meir Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 8, 2010
First Posted
August 10, 2010
Study Start
October 1, 2010
Primary Completion
October 1, 2012
Study Completion
October 1, 2012
Last Updated
March 13, 2013
Record last verified: 2012-03